4FOX Ventures
VC Fund
Luxembourg, Luxembourg
4FOX Ventures is a VC fund in Luxembourg focused on Medical Device and Medical. 4FO Ventures
- Total investments:
- 23
- Last investment:
- Lead investor:
- 52%
Last updated:
For AI agents: llms.txt
Industries 4FOX Ventures invests in
Stages 4FOX Ventures invests in
Countries 4FOX Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.8M–$3.3M
- Series A
- $1.8M–$11M
- Series B
- $5.5M–$69M
Investment Focus
Industry
- Medical Device 4 (17%)
- Medical 3 (13%)
- Health Care 3 (13%)
- Artificial Intelligence 3 (13%)
- Biotechnology 2 (9%)
Stage
- Series A 7 (30%)
- Seed 3 (13%)
- Series B 3 (13%)
- Venture - Series Unknown 2 (9%)
- Series C 1 (4%)
Country
- Switzerland 7 (30%)
- United States 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andre Hoffmann
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
|
Jean-Pierre Rosat
Managing Partner and Founder
|
Managing Partner and Founder | Total investments: 12 | Find email | |
Valentin Maxime Chenaux
General partner
|
General partner | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs. | $105.7M / Series D / Oct 13, 2025 | ||
| Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. | $2.5M / Venture - Series Unknown / Nov 14, 2024 | ||
| Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems. | $68.5M / Series B / Sep 17, 2024 | ||
| ARTIRIA Medical provides micro-actuated device allowing to treat vascular diseases. | $6M / Series A / Feb 27, 2024 | ||
| ecoRobotix contributes to an agriculture that respects the environment, focusing on soil and hydrological resources conservation and using a minimum amount of energy. ecoRobotix aims to offer precise, safe, reliable and affordable robotic solutions that simplify farmers’ life to produce healthy food. In particular, its revolutionary solar-poweredweeding robot offers a more sustainable use of herbicides while reducing farmers costs. | $51.7M / Series B / May 09, 2023 | ||
| ASPIVIX is developing a new generation of medical devices that make gynecological procedures gentler and safer for women and gynecologists. The first device, CAREVIX, is designed to prevent cervix bleeding using a suction technology to replace traumatic tenaculum (forceps). | $5M / Series A / Nov 17, 2022 | ||
| Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners. | $5.5M / Series B / Oct 24, 2022 | ||
| L2F is involved in providing services for the food service industry by creating automation and AI solutions that help them run commercial kitchens and bars. It is engineering food service with robots in kitchens. They produce products such as skyflo, servr, frybot, and pizzabot. | $4M / Series A / Jun 29, 2021 | ||
| We complement modern machine learning with topology, the science of shapes. Increased interpretability and robustness are the direct benefits of this novel approach.Our first product, Giotto Compliance (compliance.giotto.ai), facilitates the consolidation of clinical evidence in the context of regulatory processes by leveraging proprietary NLPtechnology. This state-of-the-art AI software allows significant time and cost savings for medical device companies and medical writers. | $4.3M / Jun 23, 2021 | ||
| We complement modern machine learning with topology, the science of shapes. Increased interpretability and robustness are the direct benefits of this novel approach.Our first product, Giotto Compliance (compliance.giotto.ai), facilitates the consolidation of clinical evidence in the context of regulatory processes by leveraging proprietary NLPtechnology. This state-of-the-art AI software allows significant time and cost savings for medical device companies and medical writers. | $4M / Series A / Jun 23, 2021 | ||
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does 4FOX Ventures invest in?
4FOX Ventures invests primarily in Medical Device, Medical and Health Care startups, most often at Series A and Seed stage. Most of the 23 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is 4FOX Ventures's check size?
4FOX Ventures typically joins rounds of $1.8M–$3.3M at Seed, $1.8M–$11M at Series A and $5.5M–$69M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds 4FOX Ventures participates in.
How do I contact 4FOX Ventures?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at 4FOX Ventures?
The team at 4FOX Ventures includes Andre Hoffmann (Co-Founder), Jean-Pierre Rosat (Managing Partner and Founder) and Valentin Maxime Chenaux (General partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
